tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Lawson, 16 are a SELL (7.21%), 182 are a BUY (81.98%), 24 are a HOLD (10.81%).
Analyst Peter Lawson, currently employed at BARCLAYS, carries an average stock price target met ratio of 61.67% that have a potential upside of 40.71% achieved within 295 days.
Peter Lawson’s has documented 462 price targets and ratings displayed on 48 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 17-Dec-2025.
Analyst best performing recommendations are on REPL (REPLIMUNE GROUP).
The best stock recommendation documented was for CLVS (CLOVIS ONCOLOGY) at 9/8/2015. The price target of $103 was fulfilled within 2 days with a profit of $18.62 (22.07%) receiving and performance score of 110.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2025
$65
$35.75 (122.22%)
$48
12 days ago
(12-Feb-2026)
0/4 (0%)
$36.93 (131.56%)
Hold Since 01-Dec-2022
$25
$-4.25 (-14.53%)
$20
1 months 18 days ago
(06-Jan-2026)
5/7 (71.43%)
$-2.47 (-8.99%)
181
Buy Since 20-Nov-2025
$40
$10.75 (36.75%)
$34
1 months 29 days ago
(26-Dec-2025)
11/16 (68.75%)
$11.98 (42.76%)
205
Buy Since 24-Nov-2025
$38
$8.75 (29.91%)
$32
2 months ago
(24-Dec-2025)
6/9 (66.67%)
$8.83 (30.27%)
71
Buy Since 03-Dec-2021
$34
$4.75 (16.24%)
$32
2 months ago
(24-Dec-2025)
6/14 (42.86%)
$4.83 (16.56%)
477
Which stock is Peter Lawson is most bullish on?
Which stock is Peter Lawson is most reserved on?
What Year was the first public recommendation made by Peter Lawson?
